Page last updated: 2024-11-04

rofecoxib and Constriction, Pathologic

rofecoxib has been researched along with Constriction, Pathologic in 2 studies

Constriction, Pathologic: The condition of an anatomical structure's being constricted beyond normal dimensions.

Research Excerpts

ExcerptRelevanceReference
" Ibuprofen, a non-selective COX inhibitor, at 5mg/kg, orally dosed three times a day for 5 days did not significantly affect the PWTs in CCI rats."1.34GW406381, a novel COX-2 inhibitor, attenuates spontaneous ectopic discharge in sural nerves of rats following chronic constriction injury. ( Chessell, IP; Martindale, JC; Reeve, AJ; Spanswick, D; Zhao, FY, 2007)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Zhao, FY1
Spanswick, D1
Martindale, JC1
Reeve, AJ1
Chessell, IP1
Lapner, MA1
Stephen, WJ1

Other Studies

2 other studies available for rofecoxib and Constriction, Pathologic

ArticleYear
GW406381, a novel COX-2 inhibitor, attenuates spontaneous ectopic discharge in sural nerves of rats following chronic constriction injury.
    Pain, 2007, Volume: 128, Issue:1-2

    Topics: Action Potentials; Animals; Chronic Disease; Constriction, Pathologic; Cyclooxygenase 2 Inhibitors;

2007
Rofecoxib associated with diaphragm disease.
    Canadian journal of surgery. Journal canadien de chirurgie, 2007, Volume: 50, Issue:6

    Topics: Arthritis, Rheumatoid; Constriction, Pathologic; Cyclooxygenase 2 Inhibitors; Female; Humans; Intest

2007